Jubilant Organosys
Jubilant Organosys has signed a multi-million dollar contract worth $92 mn for its proprietary
products and exclusive synthesis segment under CRAMS business for FY08.The key growth
driver going forward is from CRAMS and big contracts like this will only bolster the growth
momentum going forward. We view this as a positive development and expect an EPS upside of
Rs 3.58 per share on account of this deal. At CMP of Rs368 the stock is trading at 17.82x its
consensus EPS of Rs.20.642.Currently the stock is not rated, however we are positive on the
stock “Accumulate”
GMR Infrastructure Ltd
The company is foraying into air charter services and has earmarked a capital expenditure of Rs
7 bn for fleet acquisition which will be financed through debt: equity in the mix of 80:20. GMR
Aviation which has been set up for this venture will have an initial fleet size of 6 nine-seater
aircraft and two choppers, out of which 2 nine-seater Falcons have already been acquired.
“Accumulate”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment